Rite Aid Pre-Tax Profit Margin 2010-2023 | RADCQ
Rite Aid pre-tax profit margin from 2010 to 2023. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue.
| Rite Aid Pre-Tax Profit Margin Historical Data |
| Date |
TTM Revenue |
TTM Pre-Tax Income |
Pre-Tax Margin |
| 2023-08-31 |
$23.48B |
$-1.65B |
-7.05% |
| 2023-05-31 |
$23.73B |
$-0.96B |
-4.02% |
| 2023-02-28 |
$24.09B |
$-0.76B |
-3.14% |
| 2022-11-30 |
$24.06B |
$-0.89B |
-3.70% |
| 2022-08-31 |
$24.21B |
$-0.86B |
-3.55% |
| 2022-05-31 |
$24.42B |
$-0.64B |
-2.61% |
| 2022-02-28 |
$24.57B |
$-0.54B |
-2.21% |
| 2021-11-30 |
$24.42B |
$-0.18B |
-0.72% |
| 2021-08-31 |
$24.31B |
$-0.14B |
-0.56% |
| 2021-05-31 |
$24.18B |
$-0.05B |
-0.21% |
| 2021-02-28 |
$24.04B |
$-0.12B |
-0.50% |
| 2020-11-30 |
$23.85B |
$-0.08B |
-0.34% |
| 2020-08-31 |
$23.20B |
$-0.03B |
-0.14% |
| 2020-05-31 |
$22.58B |
$-0.07B |
-0.31% |
| 2020-02-29 |
$21.93B |
$-0.08B |
-0.37% |
| 2019-11-30 |
$21.58B |
$-0.15B |
-0.70% |
| 2019-08-31 |
$21.57B |
$-0.22B |
-1.03% |
| 2019-05-31 |
$21.62B |
$-0.63B |
-2.92% |
| 2019-02-28 |
$21.64B |
$-0.59B |
-2.73% |
| 2018-11-30 |
$21.65B |
$-0.80B |
-3.68% |
| 2018-08-31 |
$21.56B |
$-0.81B |
-3.76% |
| 2018-05-31 |
$21.48B |
$-0.05B |
-0.21% |
| 2018-02-28 |
$21.53B |
$-0.04B |
-0.20% |
| 2017-11-30 |
$17.18B |
$0.24B |
1.39% |
| 2017-08-31 |
$17.50B |
$0.29B |
1.67% |
| 2017-05-31 |
$20.18B |
$0.01B |
0.06% |
| 2017-02-28 |
$22.93B |
$0.05B |
0.21% |
| 2016-11-30 |
$30.15B |
$0.14B |
0.45% |
| 2016-08-31 |
$32.64B |
$0.22B |
0.69% |
| 2016-05-31 |
$32.27B |
$0.24B |
0.73% |
| 2016-02-29 |
$30.74B |
$0.28B |
0.90% |
| 2015-11-30 |
$29.32B |
$0.30B |
1.01% |
| 2015-08-31 |
$27.85B |
$0.30B |
1.06% |
| 2015-05-31 |
$26.71B |
$0.41B |
1.52% |
| 2015-02-28 |
$26.53B |
$0.43B |
1.61% |
| 2014-11-30 |
$26.28B |
$0.36B |
1.36% |
| 2014-08-31 |
$25.94B |
$0.32B |
1.24% |
| 2014-05-31 |
$25.70B |
$0.21B |
0.82% |
| 2014-02-28 |
$25.53B |
$0.25B |
0.98% |
| 2013-11-30 |
$25.38B |
$0.28B |
1.09% |
| 2013-08-31 |
$25.26B |
$0.27B |
1.06% |
| 2013-05-31 |
$25.22B |
$0.19B |
0.75% |
| 2013-02-28 |
$25.39B |
$0.01B |
0.03% |
| 2012-11-30 |
$26.08B |
$-0.25B |
-0.97% |
| 2012-08-31 |
$26.16B |
$-0.37B |
-1.41% |
| 2012-05-31 |
$26.20B |
$-0.42B |
-1.61% |
| 2012-02-29 |
$26.12B |
$-0.39B |
-1.50% |
| 2011-11-30 |
$25.43B |
$-0.41B |
-1.62% |
| 2011-08-31 |
$25.32B |
$-0.44B |
-1.74% |
| 2011-05-31 |
$25.21B |
$-0.54B |
-2.14% |
| 2011-02-28 |
$25.21B |
$-0.55B |
-2.17% |
| 2010-11-30 |
$25.22B |
$-0.53B |
-2.10% |
| 2010-08-31 |
$25.37B |
$-0.54B |
-2.11% |
| 2010-05-31 |
$25.53B |
$-0.45B |
-1.78% |
| 2010-02-28 |
$25.67B |
$-0.48B |
-1.87% |
| 2009-11-30 |
$25.91B |
$-2.30B |
-8.86% |
| Sector |
Industry |
Market Cap |
Revenue |
| Retail/Wholesale |
Retail - Drug Stores |
$0.000B |
$24.092B |
|
Rite Aid Corporation is on the front lines of delivering health care services and retail products to over one million Americans daily. It provides an array of whole being health products and services for the entire family through retail pharmacies across states. Through Elixir, pharmacy benefits manager, it provides pharmacy benefits and services nationwide. Its key accomplishments include: i) advancing pharmacy strategy, including rebranding retail stores and Elixir, ii) launching a new member portal at Elixir, iii) expanding business, iv) introducing three flagship remodels and v) expanding COVID-19 testing and vaccinations. The company initiates a strategic plan named RxEvolution, which includes significant rebranding, a merchandising overhaul, new marketing and integration and operational initiatives, in both Retail Pharmacy and Pharmacy Services segments.
|
